PhoenixBio Co. Ltd
6190StockTSE
¥381.00 ▲ +1.60%
12 juin 2026
6
PhoenixBio Co. Ltd
¥381.00 ▲ +1.60%
12 juin 2026
6190StockTSE

01 / À propos

PhoenixBio Co., Ltd. provides contract testing services for medical product development in Japan, the United States, and internationally. The company offers PXB-mouse, a chimeric mouse with a humanized liver used in drug development experiments; and PXB-cells, human hepatocytes for in vitro studies and experiments, as well as HBV study services. Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications. The company was founded in 2002 and is headquartered in Higashihiroshima, Japan.

Arberion
Loading market data